Related Experiment Video
Updated: Jan 27, 2026

Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
Published on: April 28, 2023
Ramucirumab: the long and winding road toward being an option for mCRC treatment
Celine Debeuckelaere1, Sabina Murgioni2, Sara Lonardi2
1a Department of Oncology , University Hospital Antwerp , Edegem , Belgium.
Introduction:
Colorectal cancer (CRC) is one of the main causes of cancer-related morbidity and mortality worldwide. Mortality is most often attributable to metastatic disease. Despite the progress achieved so far, life expectancy continues to be limited in most patients. Ramucirumab, a most recent antiangiogenic drug, is vying in the race to metastatic CRC (mCRC) treatment since its approval by the Food and Drug Administration (FDA), based on the results of the RAISE study.
Areas Covered:
This article reviews the role of ramucirumab in mCRC, including clinical indication, safety issues, and future perspectives.
Expert Opinion:
The use of Ramucirumab in clinical practice is still limited, probably due to economic burden and the lack of specific biomarkers. Future efforts will be addressed to improve our knowledge in the use of this drug and better guide us in patients' care.
Related Concept Videos
Three-Winding Transformers
In the per-unit equivalent circuit of a grounded Y-Y three-phase...
Design Example: Alignment of a Road Line Using GIS
Wind Turbine Machine Models
Induction machines interact through the rotating magnetic field generated by the stator and the rotor. The key parameter is slip, which is the difference between synchronous speed and rotor speed relative to synchronous speed. Slip is...
Design Example: Calculating Safe Diameter for Wind-Exposed Disc
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment

